CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +3,985 | $6.80 | $27K | 74,430 |
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −65,175 | 10,625 | ||
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,985 | 31,875 | ||
| 2024-02-09 | Smith Hunter C Chief Financial Officer | Option exercise | +4,063 | 79,278 | ||
| 2024-02-09 | Smith Hunter C Chief Financial Officer | Option exercise · Restricted Stock Units | −4,063 | 8,124 | ||
| 2024-02-09 | Mazabraud Yann EVP, Head of International | Option exercise | +3,438 | 7,265 | ||
| 2024-02-09 | Mazabraud Yann EVP, Head of International | Option exercise · Restricted Stock Units | −3,438 | 6,874 | ||
| 2024-02-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise | +3,438 | 6,459 | ||
| 2024-02-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Restricted Stock Units | −3,438 | 6,874 | ||
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +2,656 | 5,270 | ||
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +69,190 | $21.38 | $1.5M | 74,460 |
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −100 | $48.24 | $5K | 74,360 |
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −48,177 | $50.14 | $2.4M | 26,183 |
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −23,397 | $50.88 | $1.2M | 2,786 |
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −100 | $51.52 | $5K | 2,686 |
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 5,312 | ||
| 2024-02-09 | Shulman Joseph Chief Technical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −69,190 | 6,610 | ||
| 2024-02-09 | Cramer Pamela J. Chief Human Resources Officer | Option exercise | +2,344 | 12,466 | ||
| 2024-02-09 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Restricted Stock Units | −2,344 | 4,687 | ||
| 2024-02-01 | Lee Jennifer Kayden EVP, Head of North America | Option exercise | +4,513 | 4,513 |
Page 30 of 36 · 701 trades